
    
      Methods: We will enroll 100 subjects in a Phase I/IIa randomized, double-blind,
      placebo-controlled trial. Subjects will be assigned to one of two Mind/Body courses, each of
      which will be held once a week for 8 consecutive weeks. Each class will last 1.5-2 hours.
    
  